Investor Perspectives on Biotechnology Startups: Risk, Reward and Innovation

Alexandre Dupont
University of Milan, Italy

DOI:https://doi.org/10.5912/jcb2501

Abstract:

The biotechnology startups are a dynamic and rapidly evolving sector that provides innovative products and solutions that address contemporary problems in the healthcare, agriculture, and the environmental sustainability. But they are high capital requirements, long development cycles and strict regulatory frameworks. Based in this, this study looks into the investor perspective to biotechnology startup, looking at how the risk, reward and innovation balance. Intellectual property, clinical trial success rate, demand in the market, and other such trends like AI in drug discovery are factors that play a key role in investment considerations. The financial risks are high, but the chance of groundbreaking advancements and big money has drawn investors. Government support, investments, and technological innovations also play a role in the biotech investment landscape. It is important for investors trying to make those informed decisions in volatile and risky environment that is an industry with big rewards but high stakes.